Review



body mass  (Seca)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Seca body mass
    Body Mass, supplied by Seca, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/body mass/product/Seca
    Average 86 stars, based on 1 article reviews
    body mass - by Bioz Stars, 2026-05
    86/100 stars

    Images



    Similar Products

    standardized uptake value sulpeak lean body mass normalized peak standardized uptake value htv  (Affibody)
    86
    Affibody standardized uptake value sulpeak lean body mass normalized peak standardized uptake value htv
    Standardized Uptake Value Sulpeak Lean Body Mass Normalized Peak Standardized Uptake Value Htv, supplied by Affibody, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/standardized uptake value sulpeak lean body mass normalized peak standardized uptake value htv/product/Affibody
    Average 86 stars, based on 1 article reviews
    standardized uptake value sulpeak lean body mass normalized peak standardized uptake value htv - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    body mass  (Seca)
    86
    Seca body mass
    Body Mass, supplied by Seca, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/body mass/product/Seca
    Average 86 stars, based on 1 article reviews
    body mass - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    body mass  (Nektar Inc)
    86
    Nektar Inc body mass
    Body Mass, supplied by Nektar Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/body mass/product/Nektar Inc
    Average 86 stars, based on 1 article reviews
    body mass - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    body mass semaglutide  (Novo Nordisk)
    86
    Novo Nordisk body mass semaglutide
    A: Experimental setup showing 8-week-old ob/ob mice were maintained on chow diet throughout the experiment. On the 12th week, <t>semaglutide</t> treatment was performed daily for 3 weeks till 15th week old. B: Food consumption in both male and female after semaglutide treatment compared to vehicle group. C: Body mass of both male and female after semaglutide treatment. D & E: Fat mass and lean mass was measured by NMR across the semaglutide injection period. Data is represented as mean ± SEM *** p<0.001 and **** p<0.0001 significant difference vs. corresponding controls. n=12/group for both male and female.
    Body Mass Semaglutide, supplied by Novo Nordisk, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/body mass semaglutide/product/Novo Nordisk
    Average 86 stars, based on 1 article reviews
    body mass semaglutide - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    body mass bm  (Seca)
    86
    Seca body mass bm
    A: Experimental setup showing 8-week-old ob/ob mice were maintained on chow diet throughout the experiment. On the 12th week, <t>semaglutide</t> treatment was performed daily for 3 weeks till 15th week old. B: Food consumption in both male and female after semaglutide treatment compared to vehicle group. C: Body mass of both male and female after semaglutide treatment. D & E: Fat mass and lean mass was measured by NMR across the semaglutide injection period. Data is represented as mean ± SEM *** p<0.001 and **** p<0.0001 significant difference vs. corresponding controls. n=12/group for both male and female.
    Body Mass Bm, supplied by Seca, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/body mass bm/product/Seca
    Average 86 stars, based on 1 article reviews
    body mass bm - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    A: Experimental setup showing 8-week-old ob/ob mice were maintained on chow diet throughout the experiment. On the 12th week, semaglutide treatment was performed daily for 3 weeks till 15th week old. B: Food consumption in both male and female after semaglutide treatment compared to vehicle group. C: Body mass of both male and female after semaglutide treatment. D & E: Fat mass and lean mass was measured by NMR across the semaglutide injection period. Data is represented as mean ± SEM *** p<0.001 and **** p<0.0001 significant difference vs. corresponding controls. n=12/group for both male and female.

    Journal: bioRxiv

    Article Title: Females are protected from semaglutide-induced muscle loss in ob/ob mice

    doi: 10.64898/2026.03.03.709376

    Figure Lengend Snippet: A: Experimental setup showing 8-week-old ob/ob mice were maintained on chow diet throughout the experiment. On the 12th week, semaglutide treatment was performed daily for 3 weeks till 15th week old. B: Food consumption in both male and female after semaglutide treatment compared to vehicle group. C: Body mass of both male and female after semaglutide treatment. D & E: Fat mass and lean mass was measured by NMR across the semaglutide injection period. Data is represented as mean ± SEM *** p<0.001 and **** p<0.0001 significant difference vs. corresponding controls. n=12/group for both male and female.

    Article Snippet: Following the 4-week acclimation period, mice were randomly divided into two experimental groups where one group received daily subcutaneous injections of 3 nmol/kg body mass semaglutide (Novo Nordisk), and another group received daily subcutaneous injections of an equivalent volume of vehicle (phosphate-buffered saline, PBS).

    Techniques: Injection

    Journal: bioRxiv

    Article Title: Females are protected from semaglutide-induced muscle loss in ob/ob mice

    doi: 10.64898/2026.03.03.709376

    Figure Lengend Snippet:

    Article Snippet: Following the 4-week acclimation period, mice were randomly divided into two experimental groups where one group received daily subcutaneous injections of 3 nmol/kg body mass semaglutide (Novo Nordisk), and another group received daily subcutaneous injections of an equivalent volume of vehicle (phosphate-buffered saline, PBS).

    Techniques:

    A: Showing gonadal white adipose tissue (gWAT) and inguinal white adipose tissue (iWAT) mass of vehicle or semaglutide treated male mice. B: gWAT and iWAT mass of vehicle or semaglutide treated female mice. C: Individual muscle mass of vehicle or semaglutide treated male ob/ob mice. D: Individual muscle mass of vehicle or semaglutide treated female ob/ob mice Data is represented as mean ± SEM. * p<0.05 and ** p<0.01 significant difference vs. corresponding controls. n=12/group for both male and female.

    Journal: bioRxiv

    Article Title: Females are protected from semaglutide-induced muscle loss in ob/ob mice

    doi: 10.64898/2026.03.03.709376

    Figure Lengend Snippet: A: Showing gonadal white adipose tissue (gWAT) and inguinal white adipose tissue (iWAT) mass of vehicle or semaglutide treated male mice. B: gWAT and iWAT mass of vehicle or semaglutide treated female mice. C: Individual muscle mass of vehicle or semaglutide treated male ob/ob mice. D: Individual muscle mass of vehicle or semaglutide treated female ob/ob mice Data is represented as mean ± SEM. * p<0.05 and ** p<0.01 significant difference vs. corresponding controls. n=12/group for both male and female.

    Article Snippet: Following the 4-week acclimation period, mice were randomly divided into two experimental groups where one group received daily subcutaneous injections of 3 nmol/kg body mass semaglutide (Novo Nordisk), and another group received daily subcutaneous injections of an equivalent volume of vehicle (phosphate-buffered saline, PBS).

    Techniques:

    A: Individual mass of liver, spleen, kidney, heart masses in vehicle or semaglutide treated male mice. B: Individual lean tissue mass of vehicle and semaglutide treated female mice. Data is represented as mean ± SEM. ** p<0.01, *** p<0.001 and **** p<0.0001 significant difference vs. corresponding controls. n=12/group for both male and female.

    Journal: bioRxiv

    Article Title: Females are protected from semaglutide-induced muscle loss in ob/ob mice

    doi: 10.64898/2026.03.03.709376

    Figure Lengend Snippet: A: Individual mass of liver, spleen, kidney, heart masses in vehicle or semaglutide treated male mice. B: Individual lean tissue mass of vehicle and semaglutide treated female mice. Data is represented as mean ± SEM. ** p<0.01, *** p<0.001 and **** p<0.0001 significant difference vs. corresponding controls. n=12/group for both male and female.

    Article Snippet: Following the 4-week acclimation period, mice were randomly divided into two experimental groups where one group received daily subcutaneous injections of 3 nmol/kg body mass semaglutide (Novo Nordisk), and another group received daily subcutaneous injections of an equivalent volume of vehicle (phosphate-buffered saline, PBS).

    Techniques:

    A: A: Immunohistochemical characterization of tibialis anterior (TA) muscle fiber types. TA muscle cross-sections were stained to identify individual fiber types: Type IIb fibers appear red, Type IIa fibers appear blue, and unstained fibers (appearing black) correspond to Type IIx. Wheat germ agglutinin (WGA) labeling outlines muscle fiber borders in green, enabling clear visualization of fiber morphology and distribution. B & D: Showing muscle % fibers distribution per cross sectional area in vehicle or semaglutide treated male and female mice. C & E: Showing muscle % fiber composition in vehicle or semaglutide treated male and female mice. Data is represented as mean ± SEM. n=3/group for male and n=4/group for female.

    Journal: bioRxiv

    Article Title: Females are protected from semaglutide-induced muscle loss in ob/ob mice

    doi: 10.64898/2026.03.03.709376

    Figure Lengend Snippet: A: A: Immunohistochemical characterization of tibialis anterior (TA) muscle fiber types. TA muscle cross-sections were stained to identify individual fiber types: Type IIb fibers appear red, Type IIa fibers appear blue, and unstained fibers (appearing black) correspond to Type IIx. Wheat germ agglutinin (WGA) labeling outlines muscle fiber borders in green, enabling clear visualization of fiber morphology and distribution. B & D: Showing muscle % fibers distribution per cross sectional area in vehicle or semaglutide treated male and female mice. C & E: Showing muscle % fiber composition in vehicle or semaglutide treated male and female mice. Data is represented as mean ± SEM. n=3/group for male and n=4/group for female.

    Article Snippet: Following the 4-week acclimation period, mice were randomly divided into two experimental groups where one group received daily subcutaneous injections of 3 nmol/kg body mass semaglutide (Novo Nordisk), and another group received daily subcutaneous injections of an equivalent volume of vehicle (phosphate-buffered saline, PBS).

    Techniques: Immunohistochemical staining, Staining, Labeling

    A&B: The specific force and maximum force production capacity of soleus in both male and female mice in both the vehicle and semaglutide treated group. C&D: The specific force and maximum force production capacity of EDL between both the treatment groups in both the sexes. Data is represented as mean ± SEM. * p<0.05 significant difference vs. corresponding controls. n=12/group for both male and female.

    Journal: bioRxiv

    Article Title: Females are protected from semaglutide-induced muscle loss in ob/ob mice

    doi: 10.64898/2026.03.03.709376

    Figure Lengend Snippet: A&B: The specific force and maximum force production capacity of soleus in both male and female mice in both the vehicle and semaglutide treated group. C&D: The specific force and maximum force production capacity of EDL between both the treatment groups in both the sexes. Data is represented as mean ± SEM. * p<0.05 significant difference vs. corresponding controls. n=12/group for both male and female.

    Article Snippet: Following the 4-week acclimation period, mice were randomly divided into two experimental groups where one group received daily subcutaneous injections of 3 nmol/kg body mass semaglutide (Novo Nordisk), and another group received daily subcutaneous injections of an equivalent volume of vehicle (phosphate-buffered saline, PBS).

    Techniques:

    A: Mitochondrial efficiency (P/O ratio) of both vehicle and semaglutide treated male and female mice. B: Western blot analysis for mitochondrial OXPHOS subunits and citrate synthase for male mice. C: Western blot analysis for mitochondrial OXPHOS subunits and citrate synthase for female mice. Data is represented as mean ± SEM. * p<0.05 significant difference vs. corresponding controls. n=12/group in both male and female for high-respirometry analysis and n=6/group in both male and female for western blot.

    Journal: bioRxiv

    Article Title: Females are protected from semaglutide-induced muscle loss in ob/ob mice

    doi: 10.64898/2026.03.03.709376

    Figure Lengend Snippet: A: Mitochondrial efficiency (P/O ratio) of both vehicle and semaglutide treated male and female mice. B: Western blot analysis for mitochondrial OXPHOS subunits and citrate synthase for male mice. C: Western blot analysis for mitochondrial OXPHOS subunits and citrate synthase for female mice. Data is represented as mean ± SEM. * p<0.05 significant difference vs. corresponding controls. n=12/group in both male and female for high-respirometry analysis and n=6/group in both male and female for western blot.

    Article Snippet: Following the 4-week acclimation period, mice were randomly divided into two experimental groups where one group received daily subcutaneous injections of 3 nmol/kg body mass semaglutide (Novo Nordisk), and another group received daily subcutaneous injections of an equivalent volume of vehicle (phosphate-buffered saline, PBS).

    Techniques: Western Blot

    A: The rate of ATP production ( J ATP) in semaglutide or vehicle treated male and female ob/ob mice. B: The rate of oxygen consumption ( J O 2 ) in semaglutide or vehicle treated male and female ob/ob mice. Data is represented as mean ± SEM. * p<0.05 significant difference vs. corresponding controls. n=12/group in both male and female for high-respirometry analysis.

    Journal: bioRxiv

    Article Title: Females are protected from semaglutide-induced muscle loss in ob/ob mice

    doi: 10.64898/2026.03.03.709376

    Figure Lengend Snippet: A: The rate of ATP production ( J ATP) in semaglutide or vehicle treated male and female ob/ob mice. B: The rate of oxygen consumption ( J O 2 ) in semaglutide or vehicle treated male and female ob/ob mice. Data is represented as mean ± SEM. * p<0.05 significant difference vs. corresponding controls. n=12/group in both male and female for high-respirometry analysis.

    Article Snippet: Following the 4-week acclimation period, mice were randomly divided into two experimental groups where one group received daily subcutaneous injections of 3 nmol/kg body mass semaglutide (Novo Nordisk), and another group received daily subcutaneous injections of an equivalent volume of vehicle (phosphate-buffered saline, PBS).

    Techniques: